Chicago-based Abbott has completed its $400 million buyout of OptiMedica, according to a Mass Device report. Abbott reported paid $250 million up front and will cede another $150 million if several regulatory and sales milestones are met.
The acquisition brings femtosecond laser-assisted cataract surgery to Abbott Medical Optics' ophthalmology unit.
More Articles on Ophthalmology:
Kingston Surgery Center's Dr. Donald Savage Pens Cataract Awareness Article
Ophthalmologist Dr. David Vollman Finalist for National 'Call to Service' Medal
Poor Ophthalmic Clinic Infection Control to Blame for Pink Eye Outbreaks